Illumina PT Raised to $137.00 at Robert W. Baird (ILMN)
Equities researchers at Robert W. Baird increased their target price on shares of Illumina (NASDAQ:ILMN) from $87.00 to $137.00 in a research report issued on Friday, StockRatingsNetwork.com reports. Robert W. Baird’s price target would indicate a potential upside of 9.37% from the company’s current price.
In other Illumina news, CEO Jay Flatley unloaded 30,000 shares of the company’s stock in a transaction dated Thursday, January 9th. The shares were sold at an average price of $114.77, for a total value of $3,443,100.00. Following the completion of the transaction, the chief executive officer now directly owns 399,509 shares of the company’s stock, valued at approximately $45,851,648. The sale was disclosed in a document filed with the SEC, which can be accessed through this link.
Other equities research analysts have also recently issued reports about the stock. Analysts at JPMorgan Chase & Co. raised their price target on shares of Illumina from $120.00 to $190.00 in a research note to investors on Friday. Separately, analysts at Merrill Lynch raised their price target on shares of Illumina from $20.00 to $165.00 in a research note to investors on Friday. They now have a “buy” rating on the stock. Finally, analysts at Mizuho reiterated a “buy” rating on shares of Illumina in a research note to investors on Tuesday. They now have a $135.00 price target on the stock, up previously from $125.00. Seven equities research analysts have rated the stock with a hold rating and six have issued a buy rating to the company’s stock. The stock has a consensus rating of “Hold” and a consensus price target of $113.11.
Illumina (NASDAQ:ILMN) traded up 7.80% on Friday, hitting $135.035. 3,702,377 shares of the company’s stock traded hands. Illumina has a 52 week low of $48.00 and a 52 week high of $127.00. The stock has a 50-day moving average of $107. and a 200-day moving average of $88.. The company has a market cap of $17.068 billion and a P/E ratio of 149.47.
Illumina (NASDAQ:ILMN) last released its earnings data on Monday, October 21st. The company reported $0.45 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.40 by $0.05. The company had revenue of $357.00 million for the quarter, compared to the consensus estimate of $343.42 million. During the same quarter in the previous year, the company posted $0.41 earnings per share. The company’s revenue for the quarter was up 24.9% on a year-over-year basis. Analysts expect that Illumina will post $1.78 EPS for the current fiscal year.
Illumina, Inc (NASDAQ:ILMN) is a developer and manufacturer of life science tools and integrated systems for the analysis of genetic variation and function.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.